NCT01151202

Therapeutic Confirmatory Clinical Trial to Evaluate the Safety and Efficacy of "AG NPP709 Syrup"

Therapeutic Confirmatory Clinical Trial to Evaluate the Safety and Efficacy of "AG NPP709 Syrup" in Acute Upper Respiratory Tract Infection and Chronic Inflammatory Bronchitis Patients: Double Blinded, Randomized, Active Drug Comparative, Parallel Designed, Multi-centered, Phase III Study

• Status: Completed
• Phase: Phase 3
• Study type: Interventional
• Enrollment: 236 (actual)
• Sponsor: Ahn-Gook Pharmaceuticals Co.,Ltd · Industry
• Sex: All
• Age: 24 Months – 75 Years
• Healthy volunteers: Not accepted

Summary

The purpose of this study is to assess therapeutic confirmation of AG NPP709 syrup to evaluate the safety and efficacy in patients with acute upper respiratory tract infection and chronic inflammatory bronchitis.

Conditions

• Acute Upper Respiratory Tract Infections
• Bronchitis

Interventions

Type	Name	Description
DRUG	AG NPP709syrup

Timeline

• Start date: 2010-02-01
• Primary completion: 2010-05-01
• Completion: 2010-06-01
• First posted: 2010-06-28
• Last updated: 2010-10-05

Locations

6 sites across 1 country: South Korea